| 000 | 01572 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513100605.0 | ||
| 264 | 0 | _c19961204 | |
| 008 | 199612s 0 0 eng d | ||
| 022 | _a1046-6673 | ||
| 024 | 7 |
_a10.1681/ASN.V71105 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMathis, K M | |
| 245 | 0 | 0 |
_aRole of nitric oxide and angiotensin II in diabetes mellitus-induced glomerular hyperfiltration. _h[electronic resource] |
| 260 |
_bJournal of the American Society of Nephrology : JASN _cJan 1996 |
||
| 300 |
_a105-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAngiotensin II _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xmetabolism |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aLosartan |
| 650 | 0 | 4 |
_aNephrectomy _xadverse effects |
| 650 | 0 | 4 |
_aNitric Oxide _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNitroarginine _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aTetrazoles _xpharmacology |
| 700 | 1 | _aBanks, R O | |
| 773 | 0 |
_tJournal of the American Society of Nephrology : JASN _gvol. 7 _gno. 1 _gp. 105-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1681/ASN.V71105 _zAvailable from publisher's website |
| 999 |
_c8802815 _d8802815 |
||